
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 02, 2021, titled "Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market.".

